We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

ddPCR Brings Confidence to Leukemia Monitoring

Article   Jan 03, 2019 | by Chinmay Sheth, Marketing Manager, Clinical Diagnostics at Bio-Rad Laboratories

 
Quantifying Minimal Residual Disease in Chronic Myeloid Leukemia

Droplet digital PCR is sensitive enough to detect rare DNA sequences such as BCR-ABL gene fusions. From left: the sample is partitioned into 20,000 nanoliter-sized droplets; each droplet undergoes PCR amplification to endpoint, and droplets that contain the target DNA fluoresce; positive droplets are counted to enable absolute and precise quantification of the target sequence.

 
 
 

RELATED ARTICLES

Proteomics Up Close: An Interview With Dr Oliver Rinner

Article

We recently spoke with Dr Oliver Rinner, CEO at Biognosys, to learn more about the newest developments within the proteomics.

READ MORE

Quartet of Papers Provide a Fresh Look at Sex Differences in Dementia

Article

Four new research papers presented at the Alzheimer’s Association International Conference (AAIC), which is ongoing in Los Angeles this week, have highlighted the disparities between the sexes in onset and disease course of Alzheimer’s disease (AD). The new studies include a link between employment and slower memory decline in women, and sex-specific AD risk genes.

READ MORE

Uncovering the Secrets of the Breast Cancer Epigenome

Article

The epigenome plays a crucial role in the development of breast cancer. This exciting and rapidly evolving area of research holds great promise for new interventions – from prevention through to personalized treatment.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma Cancer Research Diagnostics Drug Discovery Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE